Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-19-017893
Filing Date
2019-09-04
Accepted
2019-09-04 17:44:24
Documents
1
Period of Report
2019-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5851
  Complete submission text file 0001437749-19-017893.txt   7334
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Issuer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 VISTA BLVD, #305 WACONIA MN 55387
Business Address
Cullen Michael T. (Reporting) CIK: 0001652996 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55242 | Film No.: 191075638